Detection for pathway effect contributing to disease in systems epidemiology with a case-control

BMJ Open

Volumn 5, Issue 1, 2015, Pages

  Ji, Jiadong ^a   Yuan, Zhongshang ^a   Zhang, Xiaoshuai ^a   Li, Fangyu ^b   Xu, Jing ^a   Liu, Ying ^c   Li, Hongkai ^a   Wang, Jia ^a   Xue, Fuzhong ^a  

^a SHANDONG UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c UMEÅ UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; BOOTSTRAPPING; CANCER PATIENT; CONTROLLED STUDY; EPIDEMIOLOGY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; POPULATION; RISK FACTOR; SIMULATION; SYSTEM EPIDEMIOLOGY; CASE CONTROL STUDY; EVALUATION STUDY; IMMUNOLOGY; LEUKEMIA, MYELOID, ACUTE; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; STATISTICAL MODEL; TH17 CELL;

ADULT; CASE-CONTROL STUDIES; FEMALE; HUMANS; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED; MODELS, STATISTICAL; RISK FACTORS; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, REGULATORY; TH17 CELLS;

EID: 84921910280     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2014-006721     Document Type: Article

References (36)

1. Haring R, Wallaschofski H. Diving through the "-omics" : the case for deep phenotyping and systems epidemiology. OMICS 2012;16:231-4.
2. Fallin MD, Kao WH. Is "X"-WAS the future for all of epidemiology. Epidemiology 2011;22:457-9; discussion 467-8.
3. Lund E, Dumeaux V. Systems epidemiology in cancer. Cancer Epidemiol Biomarkers Prev 2008;17:2954-7.
4. Hu FB. Metabolic profiling of diabetes: from black-box epidemiology to systems epidemiology. Clin Chem 2011;57:1224-6.
5. Leung EL, Cao ZW, Jiang ZH, et al. Network-based drug discovery by integrating systems biology and computational technologies. Brief Bioinform 2013;14:491-505.
6. Berg EL. Systems biology in drug discovery and development. Drug Discov Today 2014;19:113-25.
7. Zhang X, Wang W, Xiao K, et al. Translational medicine: application of omics for drug target discovery and validation. In: William CS, ed. An omics perspective on cancer research. Springer: The Netherlands, 2010:235-47.
8. Wu X, Jiang R, Zhang MQ, et al. Network-based global inference of human disease genes. Mol Syst Biol 2008;4:189.
9. Yates PD, Mukhopadhyay ND. An inferential framework for biological network hypothesis tests. BMC Bioinformatics 2013;14:94.
10. Adourian A, Jennings E, Balasubramanian R, et al. Correlation network analysis for data integration and biomarker selection. Mol Biosyst 2008;4:249-59.
11. Wang K, Li M, Bucan M. Pathway-based approaches for analysis of genomewide association studies. Am J Hum Genet 2007;81:1278-83.
12. Chen L, Zhang L, Zhao Y, et al. Prioritizing risk pathways: a novel association approach to searching for disease pathways fusing SNPs and pathways. Bioinformatics 2009;25:237-42.
13. Isci S, Ozturk C, Jones J, et al. Pathway analysis of high-throughput biological data within a Bayesian network framework. Bioinformatics 2011;27:1667-74.
14. Yu K, Li Q, Bergen AW, et al. Pathway analysis by adaptive combination of p values. Genet Epidemiol 2009;33:700-9.
15. Li C, Han J, Shang D, et al. Identifying disease related sub-pathways for analysis of genome-wide association studies. Gene 2012;503:101-9.
16. Bollobás B. Modern graph theory. Spinger-Verlag, 1998.
17. Efron B, Tibshirani RJ. An introduction to the bootstrap. New York: Chapman & Hall, 1993.
18. Efron B. Better bootstrap confidence intervals. J Am Stat Assoc 1987;82:171-85.
19. Goodman LA. The variance of the product of K random variables. J Am Stat Assoc 1962;57:54-60.
20. Sobel ME. Asymptotic confidence intervals for indirect effects in structural equation models. Sociol Methodol 1982;13:290-312.
21. Volpe E, Servant N, Zollinger R, et al. A critical function for transforming growth factor-beta, interleukin 23 and proinflammatory cytokines in driving and modulating human T(H)-17 responses. Nat Immunol 2008;9:650-7.
22. Yang L, Anderson DE, Baecher-Allan C, et al. IL-21 and TGF-beta are required for differentiation of human T(H)17 cells. Nature 2008;454:350-2.
23. Wang X, Gulbahce N, Yu H. Network-based methods for human disease gene prediction. Brief Funct Genomics 2011;10:280-93.
24. Saha S, Roman T, Galante A, et al. Network-based approaches for extending the Wnt signalling pathway and identifying context-specific sub-networks. Int J ComputBiol Drug Des 2012;5:185-205.
25. Ideker T, Sharan R. Protein networks in disease. Genome Res 2008;18:644-52.
26. Taylor IW, Wrana JL. Protein interaction networks in medicine and disease. Proteomics 2012;12:1706-16.
27. Jones RB, Gordus A, Krall JA, et al. A quantitative protein interaction network for the ErbB receptors using protein microarrays. Nature 2006;439:168-74.
28. Baranzini SE, Galwey NW, Wang J, et al. Pathway and network-based analysis of genome-wide association studies in multiple sclerosis. Hum Mol Genet 2009;18:2078-90.
29. Miller MA, Feng XJ, Li G, et al. Identifying biological network structure, predicting network behavior, and classifying network state with high dimensional model representation (HDMR). PLoS ONE 2012;7:e37664.
30. Di CB, Falda M, Toffolo G, et al. SimBioNeT: a simulator of biological network topology. IEEE/ACM Trans Comput Biol Bioinform 2012;9:592-600.
31. Kim DC, Wang X, Yang CR, et al. Learning biological network using mutual information and conditional independence. BMC Bioinformatics 2010;11(Suppl):S9.
32. Barabasi AL, Gulbahce N, Loscalzo J. Network medicine: a network-based approach to human disease. Nat Rev Genet 2011;12:56-68.
33. Barabasi AL, Oltvai ZN. Network biology: understanding the cell's functional organization. Nat Rev Genet 2004;5:101-13.
34. Spirin V, Mirny LA. Protein complexes and functional modules in molecular networks. Proc Natl Acad Sci USA 2003;100:12123-8.
35. Bettelli E, Carrier Y, Gao W, et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006;441:235-8.
36. Tian T, Yu S, Wang M, et al. Aberrant T helper 17 cells and related cytokines in bone marrow microenvironment of patients with acute myeloid leukemia. Clin Dev Immunol 2013;2013:915873.